continued OFF TOPIC wsj article
I saw that article this morning...could not
resist firing off a note to the editor. Here
is what I wrote...I should have left out the
trebling (tripling) part out, I probably just
jinked myself for the year with that. Would be
cool if I got in the paper--I don't think I've
ever gotten a letter to the editor published.
I probably pushed it with "whilst" and "noble"
but I wanted to sound more educated, ha ha.
Maybe wsj could interview me like they did
Joe Park, that'd be neat!
Mike...what are your favorite stocks?
...uh biotech, I never trade internuts because
I don't want to get rich...
Do you worry that trading stocks is like
gambling?
...uh, no. Level II is nothing like going
to longacres. Well, they closed longacres,
so I really cant remember if they are the
same. could be.
What beer do you like Mr. McFarland?
...uh, we have many microbrews here in
Seattle, but I prefer Rainier because
I am frugal. Mickys (green death) is
refreshing. I am a very cool Seattlelite.
Live in the suburbs, wear a Boeing jacket.
...with all that time online, do you get
a chance to watch the business shows--any
comments for the gurus on cnbc?
...uh mainly I just watch South Park.
or pehaps a more British persona, hope my
grammer is okay...
letter.editor@edit.wsj.com
I very much enjoyed your cover story on the biotech
investor who wont give up. There are many of us who
have been watching the behavior of the internet stocks
--whilst scratching our heads over the pitiable performance
of small and micro-cap biotechnology. Nobody can say
when the tide will finally turn, but for now maybe there is
good beach combing? As a generation-Xer, I suppose that
I have time on my side. With regards to the fellow in the
article...I would also say that it is prudent to occasionally
take a gain...and limit losses. Perhaps that is why your biotech
investor has suffered so? After trebling my portfolio balance in
the last year playing this game perhaps I have become too
hopeful for the sector. For sure I have probably only been lucky.
The risk with biotechnology stocks is large, but the goals of these
companies sound noble, and the rewards can be great.
Keep up the good work covering biotech,
I may have to renew my subscription!
(actually I am NOT renewing my subscription becuase
I don't think they pumped Ariad enough on Monday...
those Bastards! They...)
Okay market is open, I am turning off PC and
hitting the ski hill. A cold Rainier in my pocket
to ease the pain of impacts with the icy slopes!
--Mike "Daysleeper" McFarland |
